RET and breast cancer: In contrast to tight regulation in mammary epithelial cells, Stat3 signaling in breast cancer is dysregulated (Hughes and Watson, 2018), and, although indirect, it is active downstream of ERBB2 and RET (Gattelli et al., 2013; Hynes and Watson, 2010).